Cited 0 times in Scipus Cited Count

Intrinsic and Extrinsic Transcriptional Profiles That Affect the Clinical Response to PD-1 Inhibitors in Patients with Non–Small Cell Lung Cancer

DC Field Value Language
dc.contributor.authorByeon, HE-
dc.contributor.authorHaam, S-
dc.contributor.authorHan, JH-
dc.contributor.authorLee, HW-
dc.contributor.authorKoh, YW-
dc.date.accessioned2023-05-23T04:04:19Z-
dc.date.available2023-05-23T04:04:19Z-
dc.date.issued2023-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/25540-
dc.description.abstractUsing a machine learning method, we investigated the intrinsic and extrinsic transcriptional profiles that affect the clinical response to PD-1 inhibitors in 57 patients with non-small cell lung cancer (NSCLC). Among the top 100 genes associated with the responsiveness to PD-1 inhibitors, the proportion of intrinsic genes in lung adenocarcinoma (LUAD) (69%) was higher than in NSCLC overall (36%) and lung squamous cell carcinoma (LUSC) (33%). The intrinsic gene signature of LUAD (mean area under the ROC curve (AUC) = 0.957 and mean accuracy = 0.9) had higher predictive power than either the intrinsic gene signature of NSCLC or LUSC or the extrinsic gene signature of NSCLC, LUAD, or LUSC. The high intrinsic gene signature group had a high overall survival rate in LUAD (p = 0.034). When we performed a pathway enrichment analysis, the cell cycle and cellular senescence pathways were related to the upregulation of intrinsic genes in LUAD. The intrinsic signature of LUAD also showed a positive correlation with other immune checkpoint targets, including CD274, LAG3, and PDCD1LG2 (Spearman correlation coefficient > 0.25). PD-1 inhibitor-related intrinsic gene patterns differed significantly between LUAD and LUSC and may be a particularly useful biomarker in LUAD.-
dc.language.isoen-
dc.titleIntrinsic and Extrinsic Transcriptional Profiles That Affect the Clinical Response to PD-1 Inhibitors in Patients with Non–Small Cell Lung Cancer-
dc.typeArticle-
dc.identifier.pmid36612193-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818269-
dc.subject.keywordbiomarkers-
dc.subject.keywordgene expression profile-
dc.subject.keywordimmunotherapy-
dc.subject.keywordmachine learning-
dc.subject.keywordnon-small cell lung cancer-
dc.subject.keywordPD-1-
dc.subject.keywordPD-1/PD-L1-targeted therapy-
dc.subject.keywordPD-L1-
dc.subject.keywordtumor-intrinsic role-
dc.contributor.affiliatedAuthorByeon, HE-
dc.contributor.affiliatedAuthorHaam, S-
dc.contributor.affiliatedAuthorHan, JH-
dc.contributor.affiliatedAuthorLee, HW-
dc.contributor.affiliatedAuthorKoh, YW-
dc.type.localJournal Papers-
dc.identifier.doi10.3390/cancers15010197-
dc.citation.titleCancers-
dc.citation.volume15-
dc.citation.number1-
dc.citation.date2023-
dc.citation.startPage197-
dc.citation.endPage197-
dc.identifier.bibliographicCitationCancers, 15(1). : 197-197, 2023-
dc.identifier.eissn2072-6694-
dc.relation.journalidJ020726694-
Appears in Collections:
Journal Papers > Research Organization > Institute for Medical Sciences
Journal Papers > School of Medicine / Graduate School of Medicine > Thoracic & Cardiovascular Surgery
Journal Papers > School of Medicine / Graduate School of Medicine > Pathology
Journal Papers > School of Medicine / Graduate School of Medicine > Hematology-Oncology
Files in This Item:
36612193.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse